: MRTX

Mirati Therapeutics (NASDAQ: MRTX)

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops targeted therapeutics to address the genetic, epigenetic, and immunological promoters of cancer. Take a look at the 1-year chart of Mirati (NASDAQ: MRTX) below with added notations: After declining from its July peak, MRTX has now moved into a sideways trading range. While in the range, the… Continue Reading »